Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02299024 · ClinicalTrials.gov registry record · NA
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
A NA study of Opioid Use, Unspecified, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 278
- Enrollment target
- 1
- Study location
NCT02299024: Completed NA study of Opioid Use, Unspecified, sponsored by Northwestern University.
NCT02299024 is a NA study of Opioid Use, Unspecified that has completed, run by Northwestern University. The registered enrollment target is 278 participants, above the 197-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02299024, a NA study of Opioid Use, Unspecified, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 278 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators overall study objective is to improve patients knowledge and safe use of opioid pain relievers upon discharge from the Emergency Department.
Primary Outcome
The primary outcome was the patients ability to identify the medication name of their prescribed opioid pain reliever upon follow-up.
Conditions Studied
Interventions
- BEHAVIORAL Additional Opioid Information
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-05 |
| Phase | NA |
What the finished NCT02299024 record still lists
NCT02299024 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, above the 197-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (41% higher).
The record links to 1 condition, with Opioid Use, Unspecified appearing as the primary indexed condition, and to 1 intervention - of which Additional Opioid Information is the first listed.
NCT02299024 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02299024 about?
NCT02299024 is a clinical study titled "Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter". The investigators overall study objective is to improve patients knowledge and safe use of opioid pain relievers upon discharge from the Emergency Department.
What is the current status of trial NCT02299024?
This trial is currently completed. It is a NA study. The enrollment target is 278 participants. The study started on 2012-10. Estimated completion is 2013-05.
What conditions does trial NCT02299024 study?
This clinical trial studies the following conditions: Opioid Use, Unspecified.
What interventions are being tested in trial NCT02299024?
The interventions under investigation include: Additional Opioid Information (BEHAVIORAL).
Who is sponsoring clinical trial NCT02299024?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02299024 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use, Unspecified
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02299024's enrollment target sits among peer trials
278 3rd of 9 higher than 7 of 9 other Opioid Use, Unspecified trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use, Unspecified trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Utilization of Opioid Destruction Bags in the Post-op Period
ACTIVE NOT RECRUITING · NA
-
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
COMPLETED · NA
-
Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase
COMPLETED · NA
-
EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use
COMPLETED · NA
-
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
RECRUITING
-
Sensory Outcomes in Active Substance Users
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia